S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Concord Medical ServicesNeuBase TherapeuticsCELYAD SA/ADRCynata TherapeuticsAuscann Group
SymbolNYSE:CCMNASDAQ:NBSENASDAQ:CYADASX:CYPASX:AC8
Price Information
Current Price$2.59$6.56$10.72A$1.09N/A
52 Week RangeN/ABuyBuyN/AN/A
Analyst Ratings
Consensus RecommendationN/ABuyBuyN/AN/A
Consensus Price TargetN/A$14.00$34.00N/AN/A
% Upside from Price TargetN/A113.41% upside217.16% upsideN/AN/A
Trade Information
Market Cap$112.31 million$112.03 million$149.86 million$112.29 million$114.40 million
Beta-0.21.041.24N/AN/A
Average Volume4,11775,61913,818N/AN/A
Sales & Book Value
Annual Revenue$27.76 millionN/A$3.68 million$1.31 million$670,606.00
Price / Sales4.05N/A40.6185.810.00
CashflowN/AN/AN/AA$0.07 per shareN/A
Price / CashN/AN/AN/A15.962.92
Book Value$1.86 per share$0.59 per share$6.65 per shareA$0.11 per shareA$0.13 per share
Price / Book1.39N/A1.6110.090.00
Profitability
Net Income$-34,160,000.00$-26,960,000.00$-44,200,000.00N/AN/A
EPSN/AN/A($3.97)A($0.09)A($0.03)
Trailing P/E Ratio0.000.00N/AN/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/A-291.15%N/AN/AN/A
Return on Assets (ROA)N/A-259.75%N/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.86%N/A0.09%N/AN/A
Current Ratio1.64%4.41%3.98%5.74%29.74%
Quick Ratio1.63%4.41%N/A5.51%29.66%
Ownership Information
Institutional Ownership Percentage0.86%11.79%7.76%N/AN/A
Insider Ownership Percentage46.50%12.50%N/AN/AN/A
Miscellaneous
Employees5838N/AN/AN/A
Shares Outstanding43.36 million17.08 million13.94 million103.02 million317.05 million
Next Earnings Date5/5/2020 (Estimated)2/20/2020 (Estimated)3/26/2020 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel